239 Results

People

  1. Scheinberg
    Scheinberg
  2. Sadelain
    Sadelain
  3. Chiosis
    Chiosis
  4. Brentjens
    Brentjens
  5. Thompson
    Thompson
  6. Mcdevitt
    Mcdevitt
  7. Landgren
    Landgren
  8. Lesokhin
    Lesokhin
  9. Riviere
    Riviere
  10. Rosen
    Rosen

Groups

  1. Center for Hematologic Malignancies (239)
  2. Hematologic Malignancies Research (239)
  3. GSK Faculty (221)
  4. Sloan Kettering Institute Faculty (190)
  5. Department of Medicine (183)
  6. Molecular Pharmacology and Chemistry Program Faculty (163)
  7. Hematologic Malignancies, Division of (157)
  8. Tow Center for Developmental Oncology (TCDO) (93)
  9. Adult Leukemia (92)
  10. Sloan Kettering Institute Postdocs (82)
  1. "Hematologic Malignancies Research"
  2. "American Association for Cancer Research"
Formats
  1. Meeting Abstract (126)
  2. Journal Article (105)
  3. Review (5)
  4. Conference Paper (2)
  5. Editorial (1)
Groups
  1. Center for Hematologic Malignancies (239)
  2. Hematologic Malignancies Research (239)
  3. GSK Faculty (221)
  4. Sloan Kettering Institute Faculty (190)
  5. Department of Medicine (183)
  6. Molecular Pharmacology and Chemistry Program Faculty (163)

More Groups

People
  1. David Scheinberg (53)
  2. Michel Sadelain (46)
  3. Gabriela Chiosis (45)
  4. Renier Brentjens (28)
  5. Craig Thompson (19)
  6. Michael Mcdevitt (15)

More People

Years
  1. 2024 (1)
  2. 2023 (6)
  3. 2022 (9)
  4. 2021 (13)
  5. 2020 (18)
  6. 2019 (13)

More Years

Publications
  1. Cancer Research (116)
  2. Clinical Cancer Research (53)
  3. Proceedings of the American Association for Cancer Research Annual Meeting (24)
  4. Cancer Immunology Research (19)
  5. Cancer Discovery (17)
  6. Blood Cancer Discovery (4)

More Publications

Publishers
  1. American Association for Cancer Research (239)

Results (239)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Disruption of SUV39H1-mediated H3K9 methylation sustains CAR T-cell function
    Journal Article

    Jain, N.; Zhao, Z.; Koche, R. P.; Antelope, C.; Gozlan, Y.; Montalbano, A.; Brocks, D.; Lopez, M.; Dobrin, A.; Shi, Y.; more...
    Cancer Discovery (2024)

    Fulltext@MSK | Save
  • Host interactions with engineered T-cell micropharmacies
    Journal Article

    Bourne, C. M.; Wallisch, P.; Dacek, M. M.; Gardner, T. J.; Pierre, S.; Vogt, K.; Corless, B. C.; Bah, M. A.; Romero-Pichardo, J. E.; Charles, A.; more...
    Cancer Immunology Research (2023)

    Fulltext@MSK | Save
  • Epigenetic cooperativity as a therapeutic vulnerability in cancer
    Editorial

    Kazansky, Y.; Kentsis, A.
    Cancer Research (2023)

    Fulltext@MSK | Save
  • An embarrassment of riches: Three FDA-approved bispecific antibodies for relapsed refractory multiple myeloma
    Review

    Firestone, R.; Lesokhin, A. M.; Usmani, S. Z.
    Blood Cancer Discovery (2023)

    Fulltext@MSK | Save
  • Patient-derived iPSCs faithfully represent the genetic diversity and cellular architecture of human acute myeloid leukemia
    Journal Article

    Kotini, A. G.; Carcamo, S.; Cruz-Rodriguez, N.; Olszewska, M.; Wang, T.; Demircioglu, D.; Chang, C. J.; Bernard, E.; Chao, M. P.; Majeti, R.; more...
    Blood Cancer Discovery (2023)

    Fulltext@MSK | Save
  • Hypoxia potentiates the inflammatory fibroblast phenotype promoted by pancreatic cancer cell-derived cytokines
    Journal Article

    Schwörer, S.; Cimino, F. V.; Ros, M.; Tsanov, K. M.; Ng, C.; Lowe, S. W.; Carmona-Fontaine, C.; Thompson, C. B.
    Cancer Research (2023)

    Fulltext@MSK | Save
  • Programming CAR T cell tumor recognition: Tuned antigen sensing and logic gating
    Review

    Hamieh, M.; Mansilla-Soto, J.; Rivière, I.; Sadelain, M.
    Cancer Discovery (2023)

    Fulltext@MSK | Save
  • Chemotherapy-related mutational signatures reveal the origins of therapy-related myeloid neoplasms
    Meeting Abstract

    Diamond, B.; Ziccheddu, B.; Boyle, E. M.; Maclachlan, K.; Taylor, J.; Watts, J. M.; Lu, S. X.; Coffey, D. G.; Bolli, N.; Papaemmanuil, E.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • SMYD2 regulates chromatin modifier KMT2D in ER+/PIK3CA mutant breast cancer
    Meeting Abstract

    Blawski, R.; Sallaku, M.; Guo, X.; Kittane, S.; Scaltriti, M.; Luo, M.; Toska, E.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • SUV39H1 disruption enhances the persistence and anti-tumor efficacy of CD28-costimulated human CAR T cells
    Meeting Abstract

    Jain, N.; Zhao, Z.; Koche, R.; Gozlan, Y.; Brocks, D.; Raveh-Sadka, T.; Wells, D.; Dobrin, A.; Shi, Y.; Lopez, M.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save